Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Overlap myositis (OM) is a form of idiopathic inflammatory myopathy (IIM) characterized by myositis with at least one clinical and/or autoantibody overlap feature.
Biomarker and diagnostic research for overlap myositis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for overlap myositis.
56 publications have been identified in PubMed for overlap myositis. Research spans Epidemiology / Natural History (29%), Case Report / Case Series (23%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 16 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:27 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
13 |
23% |
Research summaries | 12 | 21% |
Laboratory research | 7 | 13% |
Testing and diagnosis research | 6 | 11% |
Clinical study results | 1 | 2% |
New treatment approaches | 1 | 2% |
Barbosa RA (2026). [PMID: 41930046](https://pubmed.ncbi.nlm.nih.gov/41930046/). *Cureus*. [Diagnostic / Biomarker]
Vignesh P (2026). [PMID: 41887030](https://pubmed.ncbi.nlm.nih.gov/41887030/). *Semin Arthritis Rheum*. [Epidemiology / Natural History]
Fatima S (2026). [PMID: 42037035](https://pubmed.ncbi.nlm.nih.gov/42037035/). *Immun Inflamm Dis*. [Case Report / Case Series]
Minikumari Rahulan L (2026). [PMID: 42266055](https://pubmed.ncbi.nlm.nih.gov/42266055/). *Rheumatology (Oxford)*. [Epidemiology / Natural History]
Schedler NC (2026). [PMID: 42191479](https://pubmed.ncbi.nlm.nih.gov/42191479/). *Best Pract Res Clin Rheumatol*. [Review / Meta-Analysis]
Paul JR (2026). [PMID: 42150983](https://pubmed.ncbi.nlm.nih.gov/42150983/). *Best Pract Res Clin Rheumatol*. [Review / Meta-Analysis]
Billotte M (2026). [PMID: 41376133](https://pubmed.ncbi.nlm.nih.gov/41376133/). *Journal of internal medicine*. [Epidemiology / Natural History]
Chang A (2026). [PMID: 41984803](https://pubmed.ncbi.nlm.nih.gov/41984803/). *Rheumatology (Oxford, England)*. [Epidemiology / Natural History]
Hein M (2026). [PMID: 41859227](https://pubmed.ncbi.nlm.nih.gov/41859227/). *Juntendo Med J*. [Case Report / Case Series]
Nandakumar D (2026). [PMID: 41863759](https://pubmed.ncbi.nlm.nih.gov/41863759/). *Rheumatol Ther*. [Epidemiology / Natural History]